Contract Lifecycle & Obligation Risk Intelligence

Meridian BioSystems Inc. • 4,200 Active Contracts • Last Updated: Dec 2024

Total CVaR
$127.4M
+8.2% vs Q3
Auto-Renewal Exposure
$42.8M
+12.1% 30d
Obligation Compliance
87.4%
+2.1% MoM
Avg Contract Cycle
31.2d
-4.8d vs Target
SLA Breach Rate
14.2%
+6.1pp YoY
Non-Std Deviation
18.7%
+3.4pp QoQ

Renewal Cliff Timeline — Next 24 Months (ACV $M)

Peak renewal concentration: Jan 2025 ($18.4M ACV) — Nexora Systems + 4 major vendor MSAs

Liability Clause Concentration by Category

Counterparty Risk Score Distribution

23 counterparties in "Elevated" band (70–85 score) require quarterly monitoring

Contract Cycle Time by Template Type (Days)

Contract Risk Register — Top 10 by CVaR Score

Contract Name Counterparty Category ACV Renewal Date CVaR Score Risk Flags
Nexora Systems MSA Nexora Systems Vendor $4.8M Jan 2025 91 SLA Breach Auto-Renew
LabEquip Direct Supply Agreement LabEquip International Vendor $3.2M Mar 2025 84 Unlimited Liability
BioPharm Partners Distribution License BioPharm Partners AG Customer $7.1M Jun 2025 78 IP Indemnity
Quantum Analytics SaaS Agreement Quantum Analytics Ltd Vendor $1.9M Feb 2025 76 Data Breach Exposure
GlobalMed Supply Chain MSA GlobalMed Logistics Vendor $2.4M Apr 2025 72 Force Majeure Gap
Regency Hospital System License Regency Health Network Customer $5.3M Aug 2025 69 Payment Terms 120d
DataVault Hosting Services DataVault Inc Vendor $1.1M Jan 2025 67 Standard
Pacific Research Collaboration Agreement Pacific Research Institute Partnership $3.8M Sep 2025 64 IP Ownership Dispute

Redline Cycle Time by Counterparty Type (Days)

Renewal Cliff Concentration by Month

SLA Breach Rate by Vendor Over Time (% of Contracts)

Nexora Systems breach cascade (months 9–15): 7 consecutive months above threshold triggering formal breach notice

CVaR Trend & Composition — 18-Month Historical ($M)

Goal: Reduce CVaR by 20% to $102M by Jun 2026 via auto-renewal elimination and SLA enforcement